Business Description
Nanobiotix is a Paris-based biotechnology company founded in 2003 that develops cancer treatments using engineered nanoparticles. Its main product, NBTXR3, is a tiny particle injected into tumors to make radiation therapy more effective across a wide range of cancer types. The company works with a partner in Asia to bring this treatment to patients in China, South Korea, Singapore, and Thailand.
